- Portable Oxygen Concentrators
- Stationary Oxygen Concentrators
Medical Oxygen Concentrators Market size valued USD 1,834 million in 2021 and expected to reach USD 3,627.6 million by 2028 poised to grow at CAGR of 8.9% during forecast period 2022-2028. The market growing geriatric population, the incidence of various respiratory disorders and technology advances in oxygen concentrators. Oxygen concentrators are medical equipment that extract oxygen from a gas supply by selectively removing nitrogen, resulting in an oxygen-enriched product gas spurt. Oxygen concentrators are medical devices that selectively remove nitrogen from a gas supply, producing in an oxygen-enriched product gas spurt. Air is circulated through molecular filter beds in oxygen concentrators to concentrate ambient oxygen to therapeutic levels for patient administration. Oxygen concentrators are used by patients who require supplemental oxygen for respiratory ailments such as bronchitis, emphysema, lung cancer, or acute pneumonia. Oxygen concentrators can be used at home or in hospital settings to help users meet their oxygen needs. Because of their ease of use, oxygen concentrators are becoming increasingly popular and in high demand. Moreover, several oxygen concentrators are available with different flow rate such as continuous and pulse flow devices, which are digitally monitored to help in the improved usability in across patient groups in hospital and homecare setups, which are advancing medical oxygen concentrators market revenue growth across the globe. In addition, the research report includes technology advancements; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
Fastest Growing Market
The growing ageing populations, who are vulnerable to several respiratory diseases, are expected to drive the market revenue growth over the forecast period. For Instance, in 2016, according to World Bank population statistics, population ages 65 and above is estimated to be around 8.5% of total population and projected to grow geriatric population over the forecast period, which in turn affect the market growth positively. Moreover, Chronic Obstructive Pulmonary Disease (COPD) patients are increasingly adopting oxygen concentrators for COPD management; this would drive the market revenue growth. For instance, in 2015, according to WHO, COPD estimated to cause three million deaths globally. In addition, growing consumptions of cigarettes, marijuana, and rising air pollution causing respiratory diseases, this, in turn, propels the adoption of oxygen concentrators across the patient groups.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.